Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors

Inna Jörg & Dimitrios Chronas · 2026-03-07

TL;DR

Is HRT appropriate in BRCA mutation carriers with a history of TNBC following BSO, and if so, under what clinical conditions?

AI-generated by Semantic Scholar

Authors
Inna Jörg, Dimitrios Chronas